Stoklasa Kerstin, Menges Anna-Leonie, Reutersberg Benedikt, Meuli Lorenz, Zimmermann Alexander
Department of Vascular Surgery, University Hospital Zürich, Raemistrasse 100, 8091 Zurich, Switzerland.
J Clin Med. 2023 Aug 10;12(16):5213. doi: 10.3390/jcm12165213.
Despite the development of fenestrated and branched endovascular aortic repair (f/bEVAR), the surgical management of thoraco-abdominal aortic aneurysms (TAAAs) remains a major challenge. The aim of this study was to analyse the hospital incidence and hospital mortality of patients treated for TAAAs in Switzerland. Secondary data analysis was performed using nationwide administrative discharge data from 2009-2018. Standardised incidence rates and adjusted mortality rates were calculated. A total of 885 cases were identified (83.2% nonruptured (nrTAAA), 16.8% ruptured (rTAAA)), where 69.3% were male. The hospital incidence rate for nrTAAA was 0.4 per 100,000 women and 0.9 per 100,000 men in 2009, which had doubled for both sexes by 2018. For rTAAA, there was no trend over the years. The most common procedure was f/bEVAR (44.2%), followed by OAR (39.5%), and 9.8% received a hybrid procedure. There was a significant increase in endovascular procedures over time. The all-cause mortality was 7.1% with nrTAAA and 55% with rTAAA. The mortality was lower for rTAAA when f/bEVAR or hybrid procedures were used. A ruptured aneurysm and higher comorbidity were associated with higher hospital mortality. This study demonstrates that the treatment approach has changed significantly over the observed period. The use of f/bEVAR nearly tripled in nrTAAA and doubled in rTAAA during this decade.
尽管有开窗和分支型血管腔内主动脉修复术(f/bEVAR)的发展,但胸腹主动脉瘤(TAAA)的外科治疗仍然是一项重大挑战。本研究的目的是分析瑞士接受TAAA治疗患者的医院发病率和医院死亡率。使用2009年至2018年全国范围内的行政出院数据进行二次数据分析。计算标准化发病率和调整后的死亡率。共识别出885例病例(83.2%为未破裂型(nrTAAA),16.8%为破裂型(rTAAA)),其中69.3%为男性。2009年nrTAAA的医院发病率在女性中为每10万人0.4例,在男性中为每10万人0.9例,到2018年两性发病率均翻了一番。对于rTAAA,多年来没有趋势。最常见的手术是f/bEVAR(44.2%),其次是开放手术(OAR,39.5%),9.8%接受了杂交手术。随着时间的推移,血管腔内手术显著增加。nrTAAA的全因死亡率为7.1%,rTAAA为55%。当使用f/bEVAR或杂交手术时,rTAAA的死亡率较低。动脉瘤破裂和较高的合并症与较高的医院死亡率相关。本研究表明,在观察期内治疗方法发生了显著变化。在这十年中,nrTAAA中f/bEVAR的使用增加了近两倍,rTAAA中增加了一倍。